List of Certificates of Suitability (CEPs) for r1_cep_2003_280___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-280 - Rev 03 of Joint Stock Company "grindeks" Riga Lv

score 20 · Accepted Answer

Joint Stock Company "grindeks" Riga Lv, based in Latvia, is a pharmaceutical company that stands out with its certifications from FDA.

One of their significant offerings is Zopiclone, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-280 - Rev 03

This Chemical Type CEP, issued on April 12, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1060 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for r1_cep_2003_280___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Grindeks AS

About

Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

VIDEO(s)

DIGITAL CONTENT

1 News

APIs // Active Pharmaceutical Ingredients

11 APIs

2 USDMF

8 CEP/COS

4 JDMF

3 KDMF

2 NDC API

DEVELOPMENTS

1 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

52 Dossiers

23 Europe

29 Listed Dossiers

INSPECTIONS & REGISTRATIONS

1 FDA

1 GDUFA

Grindeks AS

Joint Stock Company "Grindeks" Riga...

Zopiclone

R1-CEP 2003-280 - Rev 03

Valid

Chemical

2019-04-12

1060

Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-280 - Rev 03 of Joint Stock Company "grindeks" Riga Lv